Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-14-009232)

Filing Details

Accession Number:: 0001179110-14-009232
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2014-05-27 18:11:26
Reporting Period:: 2014-05-22

Filing Date:: 2014-05-27
Accepted Time:: 2014-05-27 18:11:26
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1353496	Kevin Guest	3838 West Parkway Blvd Salt Lake City UT 84120	Pres. Of Americas:europe, Sp	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2014-05-22	10,160	$35.47	10,160	No	4	M	Direct
Common Stock	Disposition	2014-05-22	10,160	$71.15	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock-Settled Stock Appreciation Rights	Disposition	2014-05-22	20,303	$0.00	20,303	$35.47

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
25,250	2014-04-27	2015-10-27	No	4	M	Direct

Footnotes

The shares acquired resulted from the reporting person's settlement of the stock-settled stock appreciation rights disclosed in Table II.
Weighted average price. Price range in multiple transactions was $71.00 to $71.48, inclusive.